U.S. markets closed

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.14+0.03 (+0.25%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close12.11
Open12.17
Bid11.51 x 800
Ask12.49 x 1400
Day's Range11.93 - 12.34
52 Week Range3.78 - 15.95
Volume634,441
Avg. Volume2,401,574
Market Cap699.643M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.82
Earnings DateAug 04, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript
    Motley Fool

    Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics first-quarter 2021 financial results conference call. With me is Dr. Todd Brady, president, and chief executive officer of Aldeyra. This morning we issued a press release reporting our financial results for the quarter ended March 31, 2021.

  • Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights
    Business Wire

    Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights

    Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today reported financial results for the quarter ended March 31, 2021 and provided recent business highlights.

  • ACCESSWIRE

    Aldeyra Therapeutics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 8:00 AM Eastern Time.